In particular, sEH deficiency or inhibition has been reported to reduce cardiac hypertrophy, alleviate stroke, speed recovery, and enhance endothelial function in aortic rings in aged rodents [21,22,23]. The gene discussed is EPHX2; the disease is cardiac hypertrophy.